The pandemic caused by the SARS-CoV-2 coronavirus is still looming worldwide,and the pandemic has challenged health care delivery and health care systems internationally.[1]The epidemic of seasonal influenza would occ...The pandemic caused by the SARS-CoV-2 coronavirus is still looming worldwide,and the pandemic has challenged health care delivery and health care systems internationally.[1]The epidemic of seasonal influenza would occur in the winter months.Since coronavirus disease 2019(COVID-19)and influenza share many clinical symptoms,[2]it is difficult to distinguish these two respiratory infections in the early stage.[3]Although nucleic acid testing was the gold standard to identify different virus infected diseases,false-negative nucleic acid results were reported frequently in COVID-19,[4]and its diagnostic sensitivity is less optimal.Therefore,the aim of our study is to explore and compare the clinical characteristics of COVID-19 and influenza,which could deepen the understanding of these two diseases and provide some guidance for clinicians to make a differential diagnosis.展开更多
Based on the mobile Internet, Internet of Things, big data, cloud computing,“intelligentization” and other technologies, a safe and reliable management platform for integrating information about acute ischemic strok...Based on the mobile Internet, Internet of Things, big data, cloud computing,“intelligentization” and other technologies, a safe and reliable management platform for integrating information about acute ischemic stroke (AIS) thrombolysis with unified standards should be established. The management platform should include intelligent screening of high-risk groups and servers for monitoring them, server analysis of patient medical records, a server for supervision and integrated management of patient education, an integrated system of healthcare records, and a clinical decision-support system for AIS emergencies. Such a system would constitute a standardized data capture and integrated intelligent analysis system for the key information necessary in thrombolytics. In this way a human-oriented prevention and intervention mechanism for continuous care and prevention of stroke would be formed to achieve the collection and intelligent analysis of key information in drug thrombolysis. It would provide data support for AIS thrombolytics management strategies that would improve the coverage of drug thrombolysis in primary hospitals, and also optimize AIS emergency processes to increase the success rate of thrombolysis.展开更多
基金This research was supported by a grant from the Foundation of Key Discipline Construction of Zhejiang Province for Traditional Chinese Medicine(2017XK-A3)National Key R&D Program of China(2018YFC2001405).
文摘The pandemic caused by the SARS-CoV-2 coronavirus is still looming worldwide,and the pandemic has challenged health care delivery and health care systems internationally.[1]The epidemic of seasonal influenza would occur in the winter months.Since coronavirus disease 2019(COVID-19)and influenza share many clinical symptoms,[2]it is difficult to distinguish these two respiratory infections in the early stage.[3]Although nucleic acid testing was the gold standard to identify different virus infected diseases,false-negative nucleic acid results were reported frequently in COVID-19,[4]and its diagnostic sensitivity is less optimal.Therefore,the aim of our study is to explore and compare the clinical characteristics of COVID-19 and influenza,which could deepen the understanding of these two diseases and provide some guidance for clinicians to make a differential diagnosis.
文摘Based on the mobile Internet, Internet of Things, big data, cloud computing,“intelligentization” and other technologies, a safe and reliable management platform for integrating information about acute ischemic stroke (AIS) thrombolysis with unified standards should be established. The management platform should include intelligent screening of high-risk groups and servers for monitoring them, server analysis of patient medical records, a server for supervision and integrated management of patient education, an integrated system of healthcare records, and a clinical decision-support system for AIS emergencies. Such a system would constitute a standardized data capture and integrated intelligent analysis system for the key information necessary in thrombolytics. In this way a human-oriented prevention and intervention mechanism for continuous care and prevention of stroke would be formed to achieve the collection and intelligent analysis of key information in drug thrombolysis. It would provide data support for AIS thrombolytics management strategies that would improve the coverage of drug thrombolysis in primary hospitals, and also optimize AIS emergency processes to increase the success rate of thrombolysis.
